Online citations, reference lists, and bibliographies.
← Back to Search

Update On Topical Cyclosporin A. Background, Immunology, And Pharmacology.

M. Belin, C. Bouchard, T. Phillips
Published 1990 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Systemic cyclosporin A (CsA) is currently being used for immunosuppression in solid organ transplantation. Its unique mechanism of action and low myelotoxicity have vastly improved the prognosis for patient survival. A reversible and irreversible nephrotoxicity has complicated its use. CsA works via the inhibition of both lymphokine release and subsequent activation of cytotoxic T cells. The corneal allograft model presents several unique features that make it amenable to local immunosuppressant therapy. Following topical application, CsA corneal levels have been obtained above the experimentally determined levels necessary for local immunosuppression. CsA represents one of a new class of specific, potent immunomodulators, which may improve the prognosis for patients at high risk for allograft rejection.
This paper references



This paper is referenced by
Cicatricial Conjunctivitis in Lichen Planus: A Case Report
M. Mohebbi (2018)
10.1089/omi.2012.0079
Screening for drug-induced hepatotoxicity in primary mouse hepatocytes using acetaminophen, amiodarone, and cyclosporin a as model compounds: an omics-guided approach.
Anke Van Summeren (2013)
Safety and Efficacy of Topical 0.1% And 0.05% Cyclosporine
Leopoldo Martín Baiza-Durán (2010)
10.1093/toxsci/kfq380
Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells.
Anke Van Summeren (2011)
10.1155/2014/683153
Cyclosporine A Loaded PLGA Nanoparticles for Dry Eye Disease: In Vitro Characterization Studies
Vijay D. Wagh (2014)
10.1097/00007890-199603270-00014
The effect of oral immunization on corneal allograft survival.
Y. He (1996)
10.1159/000027403
The Effect of Cyclosporin A on Cultured Rabbit Subconjunctival Fibroblast Proliferation
G. Bagci (1999)
10.1590/S0103-84782004000100020
Effects of topical 2% cyclosporine A on the corneas of dogs subjected to lamellar keratoplasty with a graft of equine pericardium preserved in glycerin: clinical and morphological evaluation
Roseli Borges Teixeira (2004)
FOR OOKP SURGERY Indications Patients with bilateral corneal blindness resulting from severe end-stage
Christopher Liu (2005)
10.3109/02713689209000737
Influence of vehicle and anterior chamber protein concentration on cyclosporine penetration through the isolated rabbit cornea.
L. Cheeks (1992)
Immunologic phenotype of hosts orally immunized with corneal alloantigens.
D. Ma (1998)
10.1016/J.IJPHARM.2004.12.015
A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics.
F. Lallemand (2005)
TOPICAL CYCLOSPORINE A FOR RECURRENT EPISODES OF GRAFT REJECTION AFTER PENETRATING KERATOPLASTY
M. Javadi (2010)
10.4068/CMJ.2008.44.3.157
Therapeutic Effects of 1% Cyclosporin A Eyedrops on Herpetic Stromal Keratitis
K. H. Lee (2008)
Topical Cyclosporine A 2% in Management of Endothelial Corneal Allograft Rejection
Rejection (2018)
10.1097/00004397-200201000-00015
Corneal Graft Rejection: Recent Updates
V. M. Tham (2002)
10.1089/JOP.1991.7.301
Safety and tolerability of two percent cyclosporine (Sandimmune) ophthalmic ointment in normal volunteers.
S. Solch (1991)
10.3109/10717544.2013.861883
Formulation and evaluation of Cyclosporin A emulgel for ocular delivery
Y. Shen (2015)
10.1089/108076802317233243
Distribution of cyclosporin A in the cornea after topical or oral administration.
J. Theng (2002)
10.1159/000089268
Experimental Posterior Perforating Ocular Injury in Rabbit Eyes: Effects of Radiotherapy with or without Intravitreal Cyclosporin on Vitreous Proliferation
S. Karaküçük (2005)
Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model
H. Liang (2012)
10.1016/S0161-6420(02)01258-7
Autologous limbal grafting combined with deep lamellar keratoplasty in unilateral eye with severe chemical or thermal burn at late stage.
Yu-feng Yao (2002)
Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody.
Y. G. He (1991)
10.1007/BF01204623
Influence of topical Cyclosporine A and dissolvent on corneal epithelium permeability of fluorescein
J. M. Benítez Del Castillo (2005)
10.3844/AJISP.2006.29.34
Topical Cyclosporine A in Corneal Graft Rejection
M. Nejabat (2006)
10.1016/B978-0-323-06387-6.00163-X
Postoperative Management of Ocular Surface Reconstruction
A. Djalilian (2011)
10.1097/ICO.0b013e318160602d
Effect of Topical Cyclosporin A on Herpetic Stromal Keratitis in a Mouse Model
K. Yoon (2008)
10.1080/08820530590931386
The Osteo-Odonto-Keratoprosthesis (OOKP)
C. Liu (2005)
10.1097/00003226-200401000-00019
Bilateral Keratoconjunctivitis Associated with Lichen Planus
M. K. Rhee (2004)
10.1016/j.jconrel.2011.01.010
Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies.
P. Aksungur (2011)
10.1016/j.survophthal.2016.12.010
Management of high-risk corneal transplantation.
Antonio Di Zazzo (2017)
10.1038/eye.1998.154
The use of combined intravenous pulse methylprednisolone and oral cyclosporin A in the treatment of corneal graft rejection: A preliminary study
D. Lam (1998)
See more
Semantic Scholar Logo Some data provided by SemanticScholar